Quick Answer Box
Where do you buy MOTS-c in Canada in 2026? The leading domestic option is Nox Peptides, currently the only Canadian retail-facing supplier publishing both purity and endotoxin lab reports per batch. Other verified Canadian suppliers carrying MOTS-c include Polar Peptides, Peptide Warehouse, Amino Pure Canada, VPeptide, Canadian Peptides, Growth Guys, Clinical Peptides, NCRP, Purity Peptides, PeptidePro Canada, and Boss Peptides.
MOTS-c essentials:
- What it is: MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the 12S rRNA region of mitochondrial DNA, making it structurally distinct from nuclear-encoded peptides.
- Mechanism class: A “mitokine”, a mitochondrial signaling peptide that influences systemic metabolism through intracellular signaling, primarily by activating AMPK (AMP-activated protein kinase) pathways.
- Research applications: Glucose metabolism regulation, insulin sensitivity, fat metabolism, exercise capacity research, age-related metabolic decline studies, mitochondrial function research.
- Status in Canada: Not approved by Health Canada as a drug; sold for laboratory research use only.
- Typical 2026 Canadian pricing: Approximately CAD $80-$160 per vial depending on strength (10mg-45mg) and supplier quality tier.
- Unique biological context: MOTS-c levels naturally decline with age, a change associated with diminished metabolic resilience.
Sold strictly for laboratory research use only, not for human consumption.
What MOTS-c Actually Is â The Mitochondrial-Derived Peptide Story
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) sits in a structurally distinct position among research peptides. Unlike most peptides that are encoded by nuclear DNA and synthesized in the cytoplasm, MOTS-c is encoded directly within mitochondrial DNA, making it part of a recently recognized class of “mitochondrial-derived peptides” (MDPs) or “mitokines”:
| Property | Specification |
|---|---|
| Compound name | MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) |
| Type | Mitochondrial-derived peptide (MDP) / Mitokine |
| Length | 16 amino acids |
| Encoding source | 12S rRNA region of mitochondrial DNA (not nuclear DNA) |
| Discovery | 2015, Lee et al., Cell Metabolism |
| Primary mechanism | AMPK pathway activation |
| Natural occurrence | Endogenously produced; levels decline with age |
| Functional classification | Mitokine, mitochondrial signaling molecule with systemic metabolic effects |
| Health Canada status | Not approved as a drug |
| Research-grade format | Lyophilized powder for reconstitution; available in 10mg, 20mg, 45mg vials |
Three features make MOTS-c distinctive in the Canadian peptide market:
- Mitochondrial DNA encoding. Unlike nuclear-encoded peptides like BPC-157 or TB-500, MOTS-c originates from the mitochondrial genome, a fundamentally different biological context.
- Mitokine functional class. MOTS-c functions as a systemic metabolic regulator through intracellular signaling, distinct from peripheral or receptor-binding mechanisms.
- Age-related decline pattern. Endogenous MOTS-c levels naturally decline with age in mammalian models, providing a unique aging-research biological context that pure synthetic peptides don’t have.
ð The MOTS-c Mechanism â How AMPK Pathway Activation Works
MOTS-c’s mechanism is fundamentally different from most other research peptides. Rather than binding to a receptor, MOTS-c functions as an intracellular signaling molecule that activates AMPK (AMP-activated protein kinase) pathways:
| Pathway / Tissue | What MOTS-c Does |
|---|---|
| AMPK pathway activation | Modulates AMP-activated protein kinase signaling, the master regulator of cellular energy balance |
| Muscle metabolism | Enhances insulin sensitivity, stimulates glucose transporters, and optimizes skeletal muscle adaptation via AMPK activation |
| Fat cell regulation | Modifies gene expression through mitonuclear communication, impacting antioxidant response elements (ARE) and metabolic pathways linked to glucose uptake and lipid utilization |
| Bone formation | Regulates TGF-β/SMAD signaling, promoting osteogenic differentiation and bone density enhancement |
| Cardiovascular function | Correlates with endothelial function, potentially improving vascular reactivity via AMPK-mediated signaling |
| Exercise capacity | Improves running capacity and endurance in preclinical mouse models; mice treated with MOTS-c ran longer and faster |
| Healthy aging | Late-life MOTS-c treatment improved physical capacity and increased median and maximum lifespan in aged mice |
ð MOTS-c vs Other Metabolic Research Peptides
| Compound | Class | Primary Mechanism | Origin |
|---|---|---|---|
| MOTS-c | Mitochondrial-derived peptide (MDP) | AMPK pathway activation; intracellular signaling | Mitochondrial DNA (12S rRNA region) |
| Semaglutide | GLP-1 receptor agonist | GLP-1 receptor binding | Synthetic analog of nuclear-encoded GLP-1 |
| Tirzepatide | Dual GLP-1 + GIP agonist | Dual receptor binding | Synthetic dual agonist |
| Retatrutide | Triple GLP-1 + GIP + glucagon agonist | Triple receptor binding | Synthetic triple agonist |
| 5-amino-1MQ | NNMT inhibitor | Methylation pathway inhibition | Small molecule |
| AOD9604 | HGH fragment | Lipolytic activity (modified hGH 176-191) | Synthetic hGH fragment |
For Canadian researchers comparing metabolic peptides, MOTS-c sits in a distinct mechanistic category: it’s the only commonly-available mitochondrial-derived peptide research compound, which makes it irreplaceable for mitokine pathway research and provides a different mechanistic angle than the GLP-1 receptor agonist class.
ð¥ Watch: Mitochondrial Peptides & Metabolic Research
Dr. Andrew Huberman covers the major categories of peptides currently in use for therapeutic and research purposes, including mitochondrial-derived peptides like MOTS-c and the cellular signaling mechanisms that set them apart from receptor-binding peptides.
ð MOTS-c Research Applications Driving Canadian Demand
| Research Domain | What’s Being Studied |
|---|---|
| Mitokine pathway research | How mitochondrial-derived peptides communicate with the rest of the body |
| Metabolic homeostasis modeling | Glucose metabolism, insulin sensitivity, energy balance regulation via AMPK signaling |
| Exercise physiology research | Endurance enhancement, exercise adaptation, recovery in preclinical and early human studies |
| Diet-induced obesity research | Whether exogenous MOTS-c can counteract metabolic disturbances from high-fat diets |
| Age-related metabolic decline | Whether MOTS-c can restore metabolic protection in aged models given the natural decline of endogenous MOTS-c levels with age |
| Mitochondrial function research | How MOTS-c influences electron transport chain efficiency and ATP production |
| Bone density research | TGF-β/SMAD signaling and osteogenic differentiation pathways |
| Cardiovascular research | Endothelial function, vascular reactivity, AMPK-mediated cardiovascular protection |
| Comparative metabolic class research | MOTS-c vs. GLP-1 class compounds on different mechanistic axes |
The 7-Point Verification Framework for Research-Grade MOTS-c
| # | Verification Signal | Why It Matters for MOTS-c Specifically |
|---|---|---|
| 1 | Independent third-party COA per batch | Self-issued COAs aren’t verification, Janoshik, MZ Biolabs, Vanguard Laboratory, or equivalent matters |
| 2 | HPLC purity â¥99% | 16-amino-acid peptide; â¥99% upper-tier purity is appropriate |
| 3 | Mass spectrometry sequence verification | Confirms all 16 amino acids correctly assembled |
| 4 | Endotoxin testing | Particularly relevant for mitochondrial pathway research where contamination would confound metabolic outcomes |
| 5 | Domestic Canadian shipping | Cuts out CBSA seizure risk; preserves cold-chain integrity |
| 6 | Research-use-only framing | Vendors marketing direct-to-consumer for personal use are working outside the legal framework |
| 7 | Tamper-evident packaging | Counterfeit defense layer; chain-of-custody assurance |
1. Nox Peptides â The Documentation Standard for Mitokine Research
Site: noxpeptides.ca
Standout claim: Only Canadian retail supplier publishing both purity AND endotoxin lab reports on MOTS-c
Best for: Researchers requiring the deepest documentation chain on mitochondrial pathway research
Nox Peptides earns the #1 spot because MOTS-c research engages metabolic and mitochondrial pathways where contamination control directly affects research outcomes. Most Canadian retailers stop at HPLC purity COAs. Nox publishes those reports plus endotoxin testing, testing typically reserved for GMP pharmaceutical manufacturing.
For MOTS-c specifically, that documentation depth matters because:
- Mitochondrial pathway research, endotoxin contamination would independently activate inflammatory signaling cascades that interfere with the AMPK pathway research outcomes MOTS-c is being studied for
- Metabolic research applications, many MOTS-c protocols measure insulin sensitivity, glucose uptake, and metabolic markers where contamination introduces confounds invisible on standard purity COAs
- Exercise capacity studies, research into endurance enhancement and exercise adaptation is sensitive to inflammatory background that endotoxin contamination introduces
The Nox brand framing: NÃX is a performance science system engineered for measurable human output, designing, synthesizing, and validating precision performance compounds with documented traceability and authorized release.
What you actually get with Nox MOTS-c:
- Per-batch purity reports from independent third-party lab
- Per-batch endotoxin reports, invisible on every other Canadian retailer’s COAs
- Mass spectrometry sequence verification
- Domestic Canadian dispatch with Canadian customer service
- Catalog adjacency, MOTS-c alongside the broader metabolic peptide category for comparative research
Browse the MOTS-c listing and per-batch lab reports at noxpeptides.ca.
2. Polar Peptides â Detailed MOTS-c Documentation
Site: polarpeptides.ca
Catalog focus: Detailed product specifications with consistent Canadian fulfillment
Polar Peptides offers MOTS-c with detailed product framing: MOTS-c is a mitochondrial-derived peptide that regulates metabolic balance and energy production. It enhances glucose metabolism, supports fat loss, and improves insulin sensitivity. MOTS-c is known for its potential to increase endurance, promote longevity, and optimize mitochondrial health for improved physical and metabolic performance.
Operationally, Polar offers reliable Canadian-domestic infrastructure: each vial contains peptides at approximately 104% of the labeled amount, providing full accuracy and consistency for research applications. Vials are standardized at 16mm diameter and 38mm height with a maximum fill capacity of 3ml, ensuring compatibility with common research-use storage and reconstitution tools. Orders ship directly from a Canadian fulfillment centre within 24 hours Monday-Friday with 2-5 business day delivery.
All peptides offered by Polar Peptides go through strict quality-control procedures, including independent third-party analytical testing for purity, identity, and consistency. The disclaimer language is research-clear: All peptides are for laboratory research use only. Not for human consumption.
3. Peptide Warehouse â Made-in-Canada MOTS-c
Site: peptidewarehouse.ca
Catalog focus: Canadian manufacturing with explicit Made-in-Canada positioning
Peptide Warehouse positions MOTS-c within their explicit “Made in Canada” framing: Peptide Warehouse is Canadian’s only seller of peptides with manufacturing facilities located in Canada. Other sellers import vials from China. With the production of the vials done in Canada, we can better control the quality and ensure the vial has the full weight of the peptide declared on the label.
For MOTS-c specifically, the under-dosing concern matters because MOTS-c is one of the higher-priced research peptides per milligram, making short-fill exposure economically meaningful. Peptide Warehouse vials hold 104% of declared label weight as standard, with mannitol disclosure framing. The HPLC tested standard applies across the catalog with appropriate Health Canada warning language alongside the product page.
4. Amino Pure Canada â Multi-Format MOTS-c Including Nasal Spray
Site: aminopurecanada.ca
Catalog focus: Multiple administration formats with detailed mechanism documentation
Amino Pure Canada offers MOTS-c in multiple research formats including the unusual nasal spray administration option. Their product framing is detailed: MOTS-c, a mitochondria-derived 16-amino-acid peptide, exhibits both cell-specific and hormonal functions, modulating AMP-activated protein kinase (AMPK) pathways to regulate metabolic stress responses and gene expression. It has been classified as a mitokine, influencing systemic metabolism through intracellular signaling.
The detailed mechanism documentation across muscle metabolism, fat cell regulation, bone formation, and cardiovascular function pathways gives researchers comprehensive context before purchase. MOTS-C from Amino Pure Canada is backed by a verified Certificate of Analysis (COA), confirming HPLC-tested purity above 98% for Canadian researchers.
Logistics: free shipping on all orders over $200 CAD, plus same-day shipping on orders placed and paid before 2 PM EST. The mannitol-free option is also available for researchers who prefer mannitol-free formulations for specific research applications.
5. VPeptide â Public Janoshik Verification with Larger Vial Format
Site: vpeptide.com
Catalog focus: 45mg vial format with public batch verification and Xpresspost shipping
VPeptide offers MOTS-c in a notably larger 45mg vial format, uncommon in the Canadian market where 10mg-20mg vials dominate. The pricing reflects this larger format at $154.99 CAD with verifiable batch documentation: Batch: MOTS-1231-001, Avg. Purity: 99.391%, Avg. Mass: 46.60 mg, Result Date: 12/01/2026.
Operationally, VPeptide offers Xpresspost Shipping with orders placed before 5 pm Eastern Standard Time shipping the same business day, and most Canadian addresses delivering in 1-2 business days. The product framing emphasizes research applications: MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within mitochondrial DNA. It is studied for its role in energy regulation, insulin sensitivity, metabolic balance, and exercise performance.
For researchers running larger-volume MOTS-c protocols, the 45mg format offers significantly better per-milligram economics than the typical 10mg-20mg formats common at other suppliers. The disclaimer language is appropriately cautious throughout.
6. Canadian Peptides â Established Generalist with MOTS-c Coverage
Site: canadianpeptides.ca
Catalog focus: Long-running domestic generalist with broad metabolic peptide coverage
Canadian Peptides has been one of the longer-running domain names in this space and carries MOTS-c alongside the broader research peptide catalog. They market a 99%+ purity standard, third-party COA verification, and fast domestic shipping, positioning themselves as the peptide source Canada researchers rely on.
For researchers building multi-year MOTS-c research programs requiring batch-to-batch consistency from a stable vendor, Canadian Peptides offers operational longevity that newer entrants haven’t built up. The product framing is research-clear with consistent disclaimer language across the catalog.
7. Growth Guys â Janoshik Public Verification
Site: growthguys.is
Catalog focus: Janoshik-verified batch testing across the metabolic peptide range
Growth Guys offers MOTS-c with the Janoshik Analytical batch verification standard that’s defined the Canadian peptide community quality benchmark in 2026. Janoshik’s public verification system at janoshik.com lets researchers look up specific batch results independently using a unique key, confirming the supplier’s published COA matches the actual lab report.
For MOTS-c specifically, the Janoshik verification matters because MOTS-c is a relatively newer and less commoditized peptide in the Canadian market, meaning batch quality variation can be more meaningful than for mature compounds like BPC-157 where production economics are well-established. Independent third-party verification provides assurance for compounds where the supplier ecosystem is still maturing.
8. Clinical Peptides â Domestic Synthesis + Loyalty
Site: clinicalpeptides.net (also clinicalpeptides.ca)
Catalog focus: Canadian-synthesized peptides with rewards program economics
Clinical Peptides has leaned into Canadian-domestic synthesis with loyalty mechanics that make sense for repeat MOTS-c buyers. Most of their peptides are now manufactured in Canada, synthesized, purified, and completed within Canada, with strict adherence to USP-grade excipient standards.
The loyalty mechanics: for every $1 spent, customers earn 1 point, with every 100 points converting into a $5 discount toward future orders, plus a referral program offering 15% off for new customers and a $20 credit per successful referral. For ongoing MOTS-c research procurement at typical Canadian pricing of $80-$160 per vial, the rewards compound meaningfully across an extended research program.
9. NCRP (National Canadian Research Peptides)
Site: ncrpcanada.com
Catalog focus: Manufacturer-direct sourcing with detailed handling guidance
NCRP runs one of the more transparent manufacturer-direct operations in the Canadian market. All of their products are manufactured in Canada and certified greater than 98% pure by HPLC, with mass spectroscopy used to confirm sequence accuracy.
Their published handling guidance is unusually detailed: peptides should be stored in a dry, cool, dark place, with refrigeration at 4°C or colder away from bright light recommended for best preservation, and reconstituted only with bacteriostatic water using an insulin needle and gentle injection technique. For a 16-amino-acid mitochondrial peptide where reconstitution technique meaningfully affects peptide integrity, that operational documentation depth matters.
10. Purity Peptides â North American Sourcing Chain
Site: puritypeptides.ca
Catalog focus: North American-sourced research peptides with per-batch documentation
Purity Peptides sets itself apart with an explicit North American sourcing narrative, marketed as North American sourced and 3rd-party tested (not China), with verified COAs and purity reports on every product. Their position is that peptide accuracy depends on synthesis quality, raw materials, and controlled production environments, environmental exposure, temperature, and handling conditions directly affect molecular stability.
For Canadian research labs working under institutional procurement requirements that mandate documented North American supply chains, Purity Peptides fits cleanly into that workflow. Their disclaimer language is research-clear: for laboratory research use only, not for human consumption.
11. PeptidePro Canada â Ontario-Based Dispatch
Site: peptideprocanada.com
Catalog focus: Focused catalog with central-Canada fulfillment speed
PeptidePro Canada offers a focused catalog with Ontario-based fulfillment. Products are typically supplied as lyophilized material in glass vials, shipped from Ontario, Canada, and provided strictly for non-clinical laboratory research by qualified facilities and trained personnel.
The Ontario-based fulfillment is a meaningful logistics advantage for researchers in central Canada, Toronto, Ottawa, and Montreal labs typically see same-province or next-province delivery times within 1-2 business days. Certificates of Analysis are published directly on product pages alongside detailed quality information rather than gated behind email requests.
12. Boss Peptides â Educational Hub with MOTS-c Coverage
Site: bosspeptides.ca
Catalog focus: Peptide catalog paired with extensive buyer-side educational content
Boss Peptides has positioned itself partly as a supplier and partly as an educational resource. Their published verification framework is consistent with serious 2026 standards: check for Health Canada approval, avoid injectable peptides sold without a prescription, and demand third-party testing, legitimate research suppliers publish Certificates of Analysis (COAs) from independent labs, showing purity, identity, and sterility.
For MOTS-c specifically, the buyer-education layer matters because the compound is newer and less broadly understood than BPC-157 or TB-500. First-time MOTS-c buyers benefit from comprehensive context on the mitochondrial-derived peptide class and the AMPK pathway research applications before committing to sourcing decisions.
ð Side-by-Side: Canadian MOTS-c Suppliers in 2026
| # | Supplier | Independent COA | Endotoxin Data | Available Strengths | Differentiator |
|---|---|---|---|---|---|
| 1 | Nox Peptides | â Public | â Public | Standard vials | Purity + endotoxin transparency |
| 2 | Polar Peptides | â | On request | Standard vials | 104% fill standard, detailed specs |
| 3 | Peptide Warehouse | â | On request | Standard vials | Made-in-Canada manufacturing |
| 4 | Amino Pure Canada | â | On request | Vial + nasal spray + mannitol-free | Multi-format options |
| 5 | VPeptide | â Janoshik | On request | 45mg larger format | Best per-mg economics; Xpresspost |
| 6 | Canadian Peptides | â | On request | 10mg standard | Long operating history |
| 7 | Growth Guys | â Janoshik | On request | Standard vials | Public batch verification |
| 8 | Clinical Peptides | â | On request | Standard vials | Loyalty rewards program |
| 9 | NCRP | â | On request | Standard vials | Manufacturer-direct |
| 10 | Purity Peptides | â Per-batch | On request | Standard vials | North American sourcing |
| 11 | PeptidePro Canada | â Public on page | On request | Standard vials | Ontario-based dispatch |
| 12 | Boss Peptides | â | On request | Standard vials | Educational hub depth |
ð MOTS-c Pricing in Canada â 2026 Market Reality
| Vial Strength | Typical 2026 Canadian Range (CAD) | Per-Mg Range | Notes |
|---|---|---|---|
| 10mg | $80-$130 | ~$8-$13/mg | Common entry research format |
| 20mg | $120-$180 | ~$6-$9/mg | Mid-range option with better per-mg economics |
| 45mg (VPeptide) | $140-$160 | ~$3-$3.50/mg | Significantly best per-mg economics for high-volume protocols |
| Nasal spray formats (Amino Pure) | $100-$150 | Variable based on concentration | Alternative administration route research |
MOTS-c pricing sits in the mid-range of Canadian research peptide pricing, meaningfully more expensive per-mg than mature compounds like BPC-157 ($8-$15/mg) but cheaper than newer high-cost compounds like retatrutide ($8-$28/mg) or tirzepatide ($7-$22/mg). The 45mg larger vial format from VPeptide delivers dramatically better per-milligram economics, meaningful for research programs with sufficient volume to use the larger format within stability windows.
Storage, Handling & Reconstitution: MOTS-c-Specific Notes
| Stage | Protocol |
|---|---|
| Receipt | Inspect packaging integrity; verify tamper-evident seals; refrigerate immediately |
| Lyophilized storage (short-term) | 4°C refrigeration, away from light |
| Lyophilized storage (long-term) | -20°C freezer, away from light |
| Reconstitution diluent | Bacteriostatic water (not plain sterile water for multi-use vials) |
| Reconstitution technique | Inject diluent slowly down vial wall; gentle swirling, no aggressive shaking |
| Post-reconstitution storage | 2-8°C refrigerated; use within manufacturer-specified window |
| Mannitol consideration | Some MOTS-c products include mannitol as a bulking agent; mannitol-free options exist for researchers preferring purer formulations |
| Disposal | Per municipal hazardous waste guidelines |
At 16 amino acids, MOTS-c handling is similar to other mid-length research peptides, gentler reconstitution technique helps preserve integrity, but the compound is more stable than longer peptides like the 39-amino-acid retatrutide.
ð Authority Sources for Canadian MOTS-c Buyers
- ðšðŠ Health Canada â Think twice before injecting peptides bought online (April 2026)
- ðšðŠ Health Canada â Drug Product Database
- ð Cell Metabolism â Lee et al. 2015: MOTS-c Discovery & Mitochondrial-Derived Peptide Biology
- ð PubMed Central â MOTS-c & AMPK Pathway Research Review
- ð Geroscience â Mitochondrial Signaling Peptides in Aging and Longevity Pathways
- ð° CBC News â Health Canada warns against unauthorized peptides (April 2026)
- âïž College of Physicians & Surgeons of Alberta â Unauthorized injectable peptides
- ð McMaster University â Research-Only Peptides Q&A
- ð McGill University Office for Science and Society
- ð World Anti-Doping Agency â Prohibited List
Frequently Asked Questions
Is MOTS-c legal to buy in Canada?
MOTS-c in Canada sits in the research-chemical category in 2026. It isn’t approved as a prescription drug by Health Canada and doesn’t carry a Canadian Drug Identification Number (DIN). It can be purchased from Canadian domestic suppliers strictly for laboratory research use, not for human consumption.
What makes MOTS-c different from other research peptides?
MOTS-c is part of a recently recognized class of mitochondrial-derived peptides (MDPs), encoded within mitochondrial DNA rather than nuclear DNA. This makes it functionally a “mitokine”, a mitochondrial signaling molecule with systemic metabolic effects. Most other research peptides are nuclear-encoded and synthesized in the cytoplasm, making MOTS-c structurally and biologically distinct.
What’s the typical price for MOTS-c in Canada?
Research-grade MOTS-c typically runs CAD $80 to $180 per vial in 2026, depending on dosage strength (10mg, 20mg, or 45mg) and supplier. Per-milligram pricing runs approximately $3-$13/mg with the larger 45mg vial format from VPeptide delivering significantly better per-mg economics than typical 10mg-20mg formats.
How does MOTS-c compare to GLP-1 receptor agonists like semaglutide?
Different mechanism categories entirely. MOTS-c works through AMPK pathway activation as a mitokine, an intracellular signaling molecule. GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) work through receptor binding at GLP-1 receptors on cell surfaces. They engage different metabolic pathways and produce different research outcomes. Many comparative metabolic studies use both classes to investigate complementary mechanisms.
What’s the AMPK pathway and why does it matter for MOTS-c research?
AMPK (AMP-activated protein kinase) is the master regulator of cellular energy balance, activated when cellular energy is low, AMPK promotes energy-generating processes and suppresses energy-consuming processes. MOTS-c activates AMPK signaling, which is the primary mechanism behind its observed effects on glucose metabolism, insulin sensitivity, exercise capacity, and metabolic regulation. AMPK is also activated by exercise and by metformin, making MOTS-c research relevant to broader metabolic and longevity research areas.
Why is endotoxin testing particularly important for MOTS-c?
MOTS-c research engages metabolic and mitochondrial pathways where contamination can confound research outcomes. Endotoxin contamination, bacterial cell wall byproducts that survive sterile filtration and aren’t detected by HPLC purity testing, would independently activate inflammatory signaling cascades that interfere with the AMPK pathway research outcomes MOTS-c is being studied for. The supplier publishing per-batch endotoxin data is investing in testing that GMP pharmaceutical manufacturers consider standard but retail peptide suppliers typically skip.
Why do MOTS-c levels naturally decline with age?
The decline reflects the broader pattern of mitochondrial dysfunction in aging. As mitochondrial DNA accumulates damage and mitochondrial function declines with age, the production of mitochondrial-derived peptides like MOTS-c decreases as well. This decline is associated with diminished metabolic resilience in aged organisms, providing the biological context for research into whether exogenous MOTS-c administration can restore metabolic protection in aged models.
Can I import MOTS-c from US suppliers?
Importing peptides into Canada from international sources carries CBSA seizure risk that’s been at record-high enforcement levels in 2026. Beyond seizure risk, peptides held in non-climate-controlled customs warehouses can degrade. Domestic Canadian sourcing cuts out customs risk and supports faster shipping cycles. Several US-based suppliers (Verified Peptides, Prime Peptides, Ion Peptide) ship to Canada but the CBSA seizure exposure makes domestic sourcing strongly preferred.
What’s the WADA status of MOTS-c?
Mitochondrial-derived peptides may be subject to World Anti-Doping Agency regulations or sport-governing-body anti-doping rules. Athletes subject to WADA Code or any sport-governing-body anti-doping rules should consult their compliance officer for current prohibited substance status before sourcing or possessing any MOTS-c compound.
What’s the difference between MOTS-c with and without mannitol?
Mannitol is a sugar-alcohol bulking agent sometimes added to lyophilized peptide vials to provide visual substance, without mannitol, a 10mg peptide vial may appear nearly empty. Mannitol-free formulations contain only the active peptide and are preferred by some researchers for protocols where the bulking agent could theoretically interact with experimental conditions. For most research applications, the difference is functionally negligible, but mannitol-free options exist (Amino Pure Canada offers a mannitol-free MOTS-c) for researchers with specific preferences.
âïž Legal Disclaimers
Research Use Only. All MOTS-c products referenced in this article are sold and intended strictly for laboratory research and in vitro experimental use. They are not intended for human consumption, injection, ingestion, inhalation, topical application, or any other form of human use, nor for veterinary use, food, or cosmetic applications.
Not Approved by Health Canada. MOTS-c is not approved as a drug by Health Canada. It does not carry a Canadian Drug Identification Number (DIN). It hasn’t been through the clinical safety and efficacy review required of authorized prescription medications.
Not Approved by the FDA. MOTS-c is similarly not approved by the U.S. Food and Drug Administration for human therapeutic use.
Health Canada Public Advisory. Health Canada has issued public advisories regarding unauthorized injectable peptide drugs sold online, citing risks including hormonal imbalance, mood swings, blood sugar imbalance, liver or kidney damage, blood clots, growth of cancerous tumours, infections, allergic reactions, and interactions with other medications.
No Medical Advice. This article is published for educational and informational purposes only. It does not constitute medical advice, prescription guidance, diagnosis, or treatment recommendation.
Anti-Doping Compliance. Mitochondrial-derived peptides including MOTS-c may be subject to World Anti-Doping Agency regulations or sport-governing-body anti-doping rules. Athletes subject to such regulations should consult their compliance officer before sourcing or possessing any MOTS-c compound.
Pricing Information. Pricing ranges referenced in this article are approximate and reflect publicly observed Canadian market data as of publication. Actual prices vary by supplier, batch, vial strength, market conditions, and individual supplier operations. Pricing information is provided for general orientation only.
Limited Human Evidence. While preclinical research on MOTS-c is substantial, including the foundational 2015 Cell Metabolism paper by Lee et al. and subsequent published research, controlled human clinical trials supporting therapeutic claims for many proposed applications remain limited. Anecdotal reports and preclinical animal data don’t constitute clinical proof of safety or efficacy in humans.
Mitochondrial Pathway Research Considerations. MOTS-c functions through mitochondrial-derived peptide signaling and AMPK pathway activation. Research design should account for the compound’s intracellular signaling mechanism, which differs fundamentally from receptor-binding peptides like GLP-1 receptor agonists.
Buyer Compliance. Buyers are solely responsible for compliance with all applicable federal, provincial, and municipal laws, regulations, and institutional policies in their jurisdiction, including Canada’s Food and Drugs Act, Controlled Drugs and Substances Act, Health Canada regulatory frameworks, and any institutional research ethics board (REB) requirements.
No Endorsement. The inclusion of any supplier in this guide reflects their public business activity in the Canadian research-use peptide market and does not constitute an endorsement, recommendation, or invitation to use MOTS-c outside a controlled laboratory research setting.
No Liability. This publication, its authors, and Nox Peptides assume no liability for decisions made by readers based on the information provided herein. Sourcing decisions and any consequences thereof are the sole responsibility of the buyer.
The 2026 Bottom Line
Buying MOTS-c in Canada in 2026 means sourcing within a research-grade-only framework on a compound that’s structurally and mechanistically distinct from most other research peptides. As a mitochondrial-derived peptide encoded within mitochondrial DNA rather than nuclear DNA, MOTS-c sits in a unique biological category that fits neither the GLP-1 receptor agonist class (semaglutide, tirzepatide, retatrutide) nor the regenerative peptide class (BPC-157, TB-500, GHK-Cu).
The unique research positioning: MOTS-c is the most accessible commonly-available mitokine research compound in the Canadian market, making it irreplaceable for AMPK pathway research, mitochondrial signaling studies, and age-related metabolic decline research. The natural age-related decline of endogenous MOTS-c levels provides a biological context that purely synthetic peptides don’t offer, making MOTS-c particularly relevant to longevity and aging research.
Nox Peptides sits at #1 on this list because the documentation depth, combined purity and endotoxin reporting per batch, is currently unmatched in the Canadian retail peptide market. For MOTS-c specifically, that documentation depth matters because mitochondrial pathway research is sensitive to inflammatory background that endotoxin contamination introduces. The remaining eleven suppliers each have legitimate strengths: detailed product specifications (Polar Peptides), Made-in-Canada manufacturing (Peptide Warehouse), multi-format including nasal spray (Amino Pure Canada), best per-mg economics with 45mg format (VPeptide), vendor stability (Canadian Peptides), Janoshik public verification (Growth Guys), loyalty rewards (Clinical Peptides), manufacturer-direct (NCRP), North American sourcing (Purity Peptides), Ontario-based dispatch (PeptidePro Canada), and educational hub depth (Boss Peptides).
What no Canadian MOTS-c buyer should compromise on in 2026: independent third-party COA verification with mass spectrometry confirmation, endotoxin testing where available, domestic Canadian shipping, and clear research-use-only framing. For a compound where mitochondrial pathway research integrity directly affects outcomes, those criteria aren’t optional, they’re the minimum baseline.
For researchers ready to source from the documentation leader, browse the MOTS-c listing and per-batch lab reports at noxpeptides.ca.